Walgreens Boots Alliance: Larger Structural Problems Remain
Walgreens-Boots Alliance struggles with margin compression, competition, and financial risks. Learn why these challenges make WBA a strong sell.
Walgreens Boots Alliance (WBA) Declines More Than Market: Some Information for Investors
The most recent trading session ended with Walgreens Boots Alliance (WBA) standing at $9.70, reflecting a -0.51% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 0.
Walgreens Boots Alliance Inc. stock outperforms competitors on strong trading day
Shares of Walgreens Boots Alliance Inc. WBA rose 1.18% to $9.47 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.27% to 6,051.97 and Dow Jones Industrial Average DJIA falling 0.50% to 44,368.56.
State of Alaska Department of Revenue Sells 28,290 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
State of Alaska Department of Revenue trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 25.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC).
Walgreens Boots Alliance sells $314 million in Cencora stock
Walgreens Boots Alliance, Inc. (NASDAQ:WBA), through its subsidiary Walgreens Boots Alliance Holdings LLC, recently reported significant stock transactions involving Cencora, Inc. (NYSE:COR), a prominent player in the Healthcare Providers & Services industry with a market capitalization of $47.
Walgreens Boots Alliance Inc. stock underperforms Monday when compared to competitors
Walgreens Boots Alliance Inc. closed 56.58% short of its 52-week high of $22.96, which the company reached on February 12th.
Cencora Announces $50 Million Share Repurchase from Walgreens Boots Alliance
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced an agreement to repurchase approximately $50 million worth of its common stock from Walgreens Boots Alliance Holdings LLC. The transaction aligns with
Walgreens Edges Closer To Selling Stake In Clinic Operator VillageMD
Walgreens is getting closer to selling its stake in doctor-staffed clinic operator VillageMD, which has already cost the ...
Why Walgreens' Dividend Suspension Shouldn't Come as a Surprise to Investors
Walgreens Boots Alliance (NASDAQ: WBA) faces an uncertain path ahead. Its financials haven't been strong in recent years, and ...
Walgreens’ VillageMD Taps Advisers as Backer Pursues Exit Plan
VillageMD, the health care clinic chain backed by Walgreens Boots Alliance Inc., is working with Evercore Inc. for assistance ...
Crain's Chicago Business19h
Moody's downgrades Walgreens outlook to negative
Despite Walgreens paying down some debt and reporting modest growth, Moody’s expects Walgreens to face negative free cash ...
WBA INVESTOR DEADLINE: Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
February 11, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and ...
Modern Healthcare2d
VillageMD taps advisers as Walgreens pursues exit plan
Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...
Crain's Chicago Business4d
Judge orders Walgreens to pay nearly $1 billion in COVID test case
In 2024, the arbitrator issued a $988 million award to PWNHealth. Walgreens disputed the alleged claims and the amount of the ...
Walgreens Boots Alliance Faces Uphill Legal Battle Following Upheld Arbitration Award
Walgreens Boots Alliance, Inc., the prominent pharmacy chain, disclosed significant legal developments in its recent 8-K filing to the U.S. Securities and Exchange Commission. The report dated ...